Search Results - "Mascolo, Annamaria"
-
1
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase
Published in Scientific reports (10-05-2019)“…We aimed to perform an analysis of individual case safety reports retrieved after the Standardized MedDRA Query “Pregnancy and neonatal topics” for which…”
Get full text
Journal Article -
2
The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure
Published in International journal of cardiology (01-01-2017)“…Abstract Chronic Heart Failure (HF) is still a disease state characterized by elevated morbidity and mortality and represents an unresolved problem for its…”
Get full text
Journal Article -
3
Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?
Published in Heart failure reviews (01-03-2020)“…Atrial fibrillation (AF) is a significant cause of morbidity and mortality as well as a public health burden considering the high costs of AF-related…”
Get full text
Journal Article -
4
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study
Published in Frontiers in immunology (03-10-2022)“…Introduction Although the European Medicines Agency (EMA) encourage coronavirus disease 2019 (COVID-19) vaccination in pregnant women, the scientific evidence…”
Get full text
Journal Article -
5
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
Published in Frontiers in immunology (13-09-2022)“…Capillary leak syndrome (CLS) emerged as new adverse event after immunization (AEFI) associated to COVID-19 vaccination. CLS is a rare condition characterized…”
Get full text
Journal Article -
6
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?
Published in Biomedicine & pharmacotherapy (01-08-2023)“…Despite the available evidence showing an association between cardiac arrhythmia and Immune Checkpoint Inhibitors (ICIs), few studies have compared this risk…”
Get full text
Journal Article -
7
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
Published in Frontiers in pharmacology (15-04-2020)“…The use of quinolones has been associated with the development of serious and persistent adverse drug reaction (ADR) mainly affecting muscles, joints and the…”
Get full text
Journal Article -
8
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database
Published in Pharmaceuticals (Basel, Switzerland) (23-01-2024)“…A potential risk of suicide associated with liraglutide or semaglutide treatments has recently emerged. Therefore, we decided to investigate the reporting…”
Get full text
Journal Article -
9
What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials
Published in Nutrients (01-07-2023)“…Chemotherapy represents the main pharmacological cancer treatment. Recently, positive effects emerged with the combination of anticancer therapy and…”
Get full text
Journal Article -
10
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
Published in Frontiers in pharmacology (13-02-2019)“…Despite several innovative medicines gaining worldwide approval in recent years, there are still therapeutic areas for which unsatisfied therapeutic needs…”
Get full text
Journal Article -
11
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
Published in Frontiers in pharmacology (20-04-2021)“…The renin-angiotensin-aldosterone system (RAAS) firstly considered as a cardiovascular circulating hormonal system, it is now accepted as a local tissue system…”
Get full text
Journal Article -
12
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis
Published in Frontiers in pediatrics (22-07-2022)“…Background Blinatumomab is a bispecific CD19-directed CD3 T-cell engager that has proven efficacy in children with relapsed or refractory B-cell acute…”
Get full text
Journal Article -
13
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
Published in Frontiers in pharmacology (16-08-2023)“…Introduction: Ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor, is authorized for the treatment of chronic lymphocytic leukemia (CLL). This study aims to…”
Get full text
Journal Article -
14
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events
Published in Pharmaceuticals (Basel, Switzerland) (27-05-2022)“…Few data have been published on the effects of impaired glucose metabolism induced by COVID-19 vaccines. We decided to perform a study to describe Individual…”
Get full text
Journal Article -
15
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
Published in Frontiers in cardiovascular medicine (21-09-2022)“…A new therapeutic class of oral agents firstly used for the treatment of type 2 diabetes mellitus is represented by gliflozines or sodium-glucose…”
Get full text
Journal Article -
16
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
Published in Pharmaceuticals (Basel, Switzerland) (25-02-2022)“…Dapagliflozin was associated with an increased risk of diabetic ketoacidosis that has led to the European withdrawal of the authorization for the type 1…”
Get full text
Journal Article -
17
Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study
Published in PloS one (28-07-2016)“…This study investigated the impact of chronic kidney disease on all-causes and cardiovascular mortality in patients with atrial fibrillation treated with…”
Get full text
Journal Article -
18
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
Published in Frontiers in pharmacology (06-11-2023)“…Background: The risk of falls and bone fractures with sodium-glucose co-transporter-2 (SGLT2) inhibitors has been characterized by conflicting evidence…”
Get full text
Journal Article -
19
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
Published in Frontiers in cardiovascular medicine (11-08-2020)“…Although clinical manifestations of the 2019 novel coronavirus disease pandemic (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2…”
Get full text
Journal Article -
20
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System
Published in Frontiers in pharmacology (07-05-2020)“…Among factors influencing the higher risk of developing unknown or rare adverse drug reactions (ADRs) among children and adolescents, there is the frequent…”
Get full text
Journal Article